Treatment of Smoldering Multiple Myeloma: Ready for Prime Time?
E. Bridget Kim, Andrew J. Yee, Noopur Raje
Abstract
The current standard of care for smoldering multiple myeloma (SMM) is observation until there is end-organ involvement. With newer and more effective treatments available, a question that is increasingly asked is whether early intervention in patients with SMM will alter the natural history of their disease. Herein, we review the evolving definition of SMM and risk stratification models. We discuss evidence supporting early intervention for SMM-both as a preventative strategy to delay progression and as an intensive treatment strategy with a goal of potential cure. We highlight ongoing trials and focus on better defining who may require early intervention.
Topics & Concepts
Intervention (counseling)Risk stratificationMultiple myelomaMedicineIntensive care medicineClinical trialNatural historyStandard of careSurgeryPathologyInternal medicineNursingMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCancer Mechanisms and Therapy